Sponsor:
UsAgainstAlzheimer's
Code:
NCT04466722
Conditions
Alzheimer Disease
Dementia
Mild Cognitive Impairment
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Alzheimer Disease
Dementia
Mild Cognitive Impairment
Study ID
NCT04466722
Start date
Aug 15, 2018
Status verified date
Jun, 2022
Completion date
Dec 31, 2023
Anticipated
Primary completion date
Dec 31, 2023
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Enrollment
10000 participants
Anticipated
Primary outcome measure
Central contacts
Locations
UsAgainstAlzheimer's
Recruiting
Washington, District of Columbia, United States, 20043
Contacts
Principal Investigator:
Theresa Frangiosa, MBA
Sponsor
UsAgainstAlzheimer's
Last update posted
Jun 15, 2022
Last verified
Jun, 2022
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by UsAgainstAlzheimer's on 2022-06-15.